Diana Noronha Nunes
Overview
Explore the profile of Diana Noronha Nunes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garrido J, Bernal Y, Gonzalez E, Blanco A, Sepulveda-Hermosilla G, Freire M, et al.
BMC Cancer
. 2024 Aug;
24(1):951.
PMID: 39097719
Background: Tobacco use is one of the main risk factors for Lung Cancer (LC) development. However, about 10-20% of those diagnosed with the disease are never-smokers. For Non-Small Cell Lung...
2.
Mezmale L, Slefarska-Wolak D, Bhandari M, Ager C, Veliks V, Patsko V, et al.
J Breath Res
. 2024 Mar;
18(2).
PMID: 38467063
Volatilomics is a powerful tool capable of providing novel biomarkers for the diagnosis of gastric cancer. The main objective of this study was to characterize the volatilomic signatures of gastric...
3.
Ruano A, Guimaraes A, Braun A, Flores B, Tariki M, Abdallah E, et al.
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499015
Cancer is primarily a disease in which late diagnosis is linked to poor prognosis, and unfortunately, detection and management are still challenging. Circulating tumor cells (CTCs) are a potential resource...
4.
Takenaka I, Bartelli T, Defelicibus A, Sendoya J, Golubicki M, Robbio J, et al.
Front Oncol
. 2022 Apr;
12:809441.
PMID: 35392220
The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present...
5.
Ramalho Buttura J, Santos M, Valieris R, Drummond R, Defelicibus A, Lima J, et al.
Cancers (Basel)
. 2021 Jan;
13(3).
PMID: 33513945
DNA mismatch repair deficiency (dMMR) is associated with the microsatellite instability (MSI) phenotype and leads to increased mutation load, which in turn may impact anti-tumor immune responses and treatment effectiveness....
6.
Valieris R, Amaro L, Osorio C, Bueno A, Rosales Mitrowsky R, Carraro D, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33316873
DNA repair deficiency (DRD) is an important driver of carcinogenesis and an efficient target for anti-tumor therapies to improve patient survival. Thus, detection of DRD in tumors is paramount. Currently,...
7.
Branco G, Valieris R, Venezian Povoa L, de Araujo L, Fernandes G, de Souza J, et al.
Genet Mol Biol
. 2020 May;
43(2):e20180351.
PMID: 32352476
Next-generation sequencing (NGS) platforms allow the analysis of hundreds of millions of molecules in a single sequencing run, revolutionizing many research areas. NGS-based microRNA studies enable expression quantification in unprecedented...
8.
de Amorim M, Branco G, Valieris R, Tarcitano E, Tojal Da Silva I, de Araujo L, et al.
Pharmacogenomics
. 2019 May;
20(7):493-502.
PMID: 31124410
HER2 upregulation is related with poor outcome in many tumor types. Whereas anti-HER2 treatment is the standard approach as adjuvant therapy in HER2-overexpressing breast cancer, the frequent relapses reinforce the...
9.
Assumpcao P, Thomaz Araujo T, de Assumpcao P, Barra W, Khayat A, Assumpcao C, et al.
Eur J Clin Microbiol Infect Dis
. 2019 May;
38(9):1591-1597.
PMID: 31114971
Despite being one of the most studied cancer-related infections, the relationship between Helicobacter pylori infection and gastric adenocarcinoma (GC) remains, in some points, obscure. Based on a critical analysis of...
10.
Abdallah E, Braun A, Flores B, Senda L, Urvanegia A, Calsavara V, et al.
Oncologist
. 2019 Mar;
24(9):e854-e863.
PMID: 30846515
Background: Gastric adenocarcinoma (GAC) is the third deadliest malignant neoplasm worldwide, mostly because of late disease diagnosis, low chemotherapy response rates, and an overall lack of tumor biology understanding. Therefore,...